CRISPR gene editing combined with magnetocaloric activation: A new strategy to assist precision medicine in cancer
In current cancer treatment, inducing tumor cell to apoptosis is a key strategy, since tumor cells gain uncontrolled proliferation ability by mechanism of inhibiting normal apoptosis. Gene editing technology, especially the CRISPR-Cas9 system, has received widespread attention due to its ability to precisely regulate the cellular functions. However, the precise control of the system in human body still faces challenges. Combined with magnetothermal therapy, its high permeability and low toxicity can be utilized to provide a new cancer treatment method by controlling the thermal effects and synergistically utilizing CRISPR-Cas9 technology. This magnetothermal - gene editing synergistic therapy demonstrates the promising therapeutic potential and provides a new strategy for precision medicine in cancer. Recently, a research paper entitled Magnetothermal activated gene editing strategy for enhanced turbine cell apoptosis, was published in Journal of Nanobiotechnology (Top of Zone 1, if: 1...
Comments
Post a Comment